Amylyx Pharmaceuticals inc. (AMLX) PT Lowered to $3.50 at BofA Securities
Tweet Send to a Friend
BofA Securities analyst Geoff Meacham lowered the price target on Amylyx Pharmaceuticals inc. (NASDAQ: AMLX) to $3.50 (from $4.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
